查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1948624

2026年全球病毒诊断检测套组市场报告

Viral Diagnostic Test Kits Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，病毒诊断检测套组市场成长显着，预计将从2025年的174.8亿美元成长到2026年的188.8亿美元，复合年增长率为8.0%。过去几年的增长可归因于多种因素，包括病毒感染疾病的再次爆发、临床诊断检查室的扩张、基于PCR的检测方法的日益普及、对疾病早期检测需求的增加以及检查室基础设施的改善。

预计未来几年病毒诊断检测套组市场将维持强劲成长，2030年市场规模将达到248.7亿美元，复合年增长率（CAGR）为7.1%。预测期内的成长要素包括：为应对未来流行病做好准备的力度加大、对分散式检查的需求不断增长、分子诊断投资增加、居家检测解决方案的推广以及检测灵敏度和速度方面的技术进步。预测期内的主要趋势包括：快速诊断检测套组的广泛应用、基于分子技术的病毒检测方法的日益普及、对就地检验解决方案的需求不断增长、多重病毒检测技术的快速发展以及对高灵敏度诊断准确性的日益重视。

病毒感染疾病的不断增加预计将在未来几年推动病毒诊断检测套组市场的成长。病毒感染疾病是由微小的病毒引起的，这些病毒侵入宿主细胞并在其中复製，可能导致从轻微疾病到严重生命的严重疾病等一系列症状。导致病毒感染疾病增加的因素包括国际旅行、都市化、不安全的注射行为以及及时诊断和治疗的匮乏。病毒诊断检测套组能够检测血液和拭子等生物检体中的病毒核酸（RNA或DNA）、抗原和抗体，在识别感染、确定治疗方案和控制其传播方面发挥着至关重要的作用。例如，根据美国疾病管制与预防中心（CDC）2025年4月发布的报告，2023年新增急性乙型肝炎病例2214例，考虑到漏报情况，实际感染人数估计约为14,400例。报告也显示，2023年新增慢性B型肝炎病例17,650例，新增急性C型肝炎病例4,966例，新增慢性C型肝炎病例101,525例。因此，病毒感染疾病的上升趋势正在推动病毒诊断检测套组市场的成长。

为了保持竞争优势，病毒诊断检测套组市场的主要企业正致力于开发创新产品，例如病毒检测试剂盒。病毒检测试剂盒是一种诊断工具，能够检测生物检体中的特定病毒，并提供快速且准确的结果，从而支持有效的疾病监测和控制。例如，英国公司BlueStain Global Ltd于2024年8月推出了MPox病毒检测试剂盒。 BlueStain的MPox病毒检测试剂盒是一种快速诊断测试，能够快速且准确地识别MPox病毒，只需15至30分钟即可获得结果。这款创新试剂盒旨在透过实现MPox疫情的早期发现和控制，尤其是在资源匮乏的地区，来改善公共卫生应对措施。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球病毒诊断检测套组市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 数位化、云端运算、巨量资料、网路安全
    • 工业4.0和智慧製造
    • 人工智慧（AI）和自主人工智慧
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 扩大快速诊断试剂盒的引入
    • 扩大基于分子技术的病毒检测方法的应用
    • 对就地检验解决方案的需求日益增长
    • 扩展多重病毒检测方法的发展
    • 人们越来越关注高灵敏度诊断准确性

第五章 终端用户产业市场分析

  • 医院
  • 诊断检查室
  • 诊所
  • 研究所
  • 公共卫生机构

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球病毒诊断检测套组市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球病毒诊断检测套组市场规模、比较及成长率分析
  • 全球病毒诊断检测套组市场表现：规模与成长，2020-2025年
  • 全球病毒诊断检测套组市场预测：规模与成长，2025-2030年，2035年预测

第八章 全球潜在市场总量（TAM）

第九章 市场细分

  • 透过检验方法
  • 传统检测、快速检测
  • 按测试类型
  • 直接萤光抗体 (DFA) 检测、层析法检测、逆转录聚合酵素链锁反应(RT-PCR) 检测、凝集试验、固相检测、流通式检测及其他检测类型
  • 最终用户
  • 实验室、诊所、医院和其他最终用户
  • 按类型细分：传统侦测
  • 酵素免疫分析法（ELISA）、聚合酵素链锁反应（PCR）检测、西方墨点法、病毒培养试验
  • 按类型细分：快速侦测
  • 横向流动化验(LFA)、免疫疾病层析试纸检测、逆转录恒温环型核酸扩增(RT-LAMP)、快速抗原检测

第十章 区域与国家分析

  • 全球病毒诊断检测套组市场：依地区、绩效及预测划分，2020-2025年、2025-2030年预测、2035年预测
  • 全球病毒诊断检测套组市场：按国家、性能和预测划分，2020-2025 年、2025-2030 年预测、2035 年预测

第十一章 亚太市场

第十二章：中国市场

第十三章 印度市场

第十四章 日本市场

第十五章：澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章：西欧市场

第21章英国市场

第22章 德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章 东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第30章：加拿大市场

第31章 南美洲市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第35章 市场监理与投资环境

第三十六章：竞争格局与公司概况

  • 病毒诊断检测套组市场：竞争格局及市场占有率（2024年）
  • 病毒诊断检测套组市场：公司估值矩阵
  • 病毒诊断检测套组市场：公司概况
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation
    • Siemens Healthineers AG

第37章：其他领先和创新企业

  • Becton Dickinson and Company, Quest Diagnostics Incorporated, Grifols SA, Hologic Inc., PerkinElmer Inc., bioMerieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., QIAGEN NV, Ortho Clinical Diagnostics, Seegene Inc., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin SpA, Trinity Biotech plc

第38章 全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年病毒诊断检测套组市场：提供新机会的国家
  • 2030年病毒诊断检测套组市场：新兴细分市场机会
  • 2030年病毒诊断检测套组市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MVDTK01_G26Q1

Viral diagnostic test kits are instruments used in medicine to detect viral infections in clinical samples from patients. These kits typically contain reagents, antibodies, or other substances that interact with specific viral antigens or genetic material, generating a measurable signal. They can detect viral particles, antigens, or genetic material (such as RNA or DNA) in samples such as blood, saliva, nasal swabs, or other bodily fluids.

The main types of viral diagnostic test kits include traditional tests and rapid tests. Traditional viral diagnostic tests are established laboratory-based methods that involve culturing the virus, detecting viral antigens, or measuring antibody responses. Examples of these tests include direct fluorescent antibody (DFA) tests, immunochromatographic assays, reverse transcriptase polymerase chain reaction (rt-PCR) based tests, agglutination assays, solid phase assays, flow through assays, and others. These tests are used by various end-users including research laboratories, clinics, hospitals, and others.

Tariffs are impacting the viral diagnostic test kits market by increasing costs of imported reagents, enzymes, antibodies, plastic consumables, and analytical instruments required for molecular and rapid testing. Diagnostic laboratories and healthcare systems in North America and Europe are most affected due to dependence on global reagent supply chains, while Asia-Pacific faces pricing pressure on kit exports. These tariffs are raising test kit prices and affecting inventory planning. However, they are also driving domestic reagent manufacturing, regional production expansion, and strategic stockpiling initiatives to strengthen diagnostic supply chain resilience.

The viral diagnostic test kits market research report is one of a series of new reports from The Business Research Company that provides viral diagnostic test kits market statistics, including viral diagnostic test kits industry global market size, regional shares, competitors with a viral diagnostic test kits market share, detailed viral diagnostic test kits market segments, market trends and opportunities, and any further data you may need to thrive in the viral diagnostic test kits industry. This viral diagnostic test kits market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The viral diagnostic test kits market size has grown strongly in recent years. It will grow from $17.48 billion in 2025 to $18.88 billion in 2026 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to recurring outbreaks of viral infections, expansion of clinical diagnostic laboratories, increased adoption of PCR-based testing, rising demand for early disease detection, improvements in laboratory infrastructure.

The viral diagnostic test kits market size is expected to see strong growth in the next few years. It will grow to $24.87 billion in 2030 at a compound annual growth rate (CAGR) of 7.1%. The growth in the forecast period can be attributed to increasing preparedness for future pandemics, growing demand for decentralized testing, rising investments in molecular diagnostics, expansion of home-based testing solutions, technological advancements in assay sensitivity and speed. Major trends in the forecast period include increasing adoption of rapid diagnostic test kits, rising use of molecular-based viral detection, growing demand for point-of-care testing solutions, expansion of multiplex viral assay development, enhanced focus on high-sensitivity diagnostic accuracy.

The increasing prevalence of viral infections is expected to drive the growth of the viral diagnostic test kits market in the coming years. Viral infections are caused by microscopic viruses that invade host cells, replicate within them, and can result in symptoms ranging from mild illness to severe, life-threatening conditions. The rise in viral infections is influenced by factors such as global travel, urbanization, unsafe injection practices, and limited access to timely diagnosis and treatment. Viral diagnostic test kits, which detect viral nucleic acids (RNA or DNA), antigens, or antibodies in biological samples such as blood or swabs, play a crucial role in identifying infections, guiding treatment decisions, and controlling outbreaks. For example, in April 2025, the Centers for Disease Control and Prevention (CDC), a US-based federal agency, reported 2,214 new acute hepatitis B cases in 2023, corresponding to an estimated 14,400 infections after accounting for underreporting, along with 17,650 newly reported chronic hepatitis B cases. The same report also recorded 4,966 new acute hepatitis C cases and 101,525 new chronic hepatitis C cases in 2023. Consequently, the growing prevalence of viral infections is fueling the viral diagnostic test kits market.

Leading companies in the viral diagnostic test kits market are focusing on developing innovative products, such as virus detection kits, to maintain their competitive edge. A virus detection kit is a diagnostic tool designed to detect specific viruses in biological samples, offering quick and accurate results to support effective disease monitoring and management. For example, in August 2024, BlueStain Global Ltd, a UK-based company, introduced the MPox virus detection kit. The Bluestain MPox virus detection kit is a rapid diagnostic test that identifies the mpox virus with high speed and accuracy, providing results in just 15 to 30 minutes. This innovative kit aims to improve public health responses by enabling early detection and containment of mpox outbreaks, especially in resource-limited environments.

In June 2023, Avacta Life Sciences, a UK-based company in the life sciences sector, completed the acquisition of Coris Bioconcept for £7.4 million ($9.35 million). This strategic move by Avacta is aimed at bolstering its rapid diagnostic test portfolio, thereby strengthening its capabilities in healthcare diagnostics and expanding its market presence, particularly in the fields of infectious disease management and point-of-care testing. Coris Bioconcept, based in Belgium, specializes in the development and manufacturing of rapid diagnostic test kits, primarily focusing on lateral flow tests designed to detect viral and bacterial pathogens.

Major companies operating in the viral diagnostic test kits market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Becton Dickinson and Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMerieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Ortho Clinical Diagnostics, Seegene Inc., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Trinity Biotech plc

North America was the largest region in the viral diagnostic test kits market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral diagnostic test kits market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the viral diagnostic test kits market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The viral diagnostic test kits market consists of sales of viral culture kits, molecular diagnostic kits, antibody detection kits, antigen detection kits, and multiplex PCR kits. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Viral Diagnostic Test Kits Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses viral diagnostic test kits market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for viral diagnostic test kits ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viral diagnostic test kits market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Testing Approach: Traditional Tests; Rapid Test
  • 2) By Test Type: Direct Fluorescent Antibody (DFA) Test; Immunochromatographic Assay; Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Based Test; Agglutination Assay; Solid Phase Assay; Flow Through Assay; Other Test Types
  • 3) By End-User: Research Laboratories; Clinics; Hospitals; Other End Users
  • Subsegments:
  • 1) By Traditional Tests: Enzyme-Linked Immunosorbent Assay (ELISA); Polymerase Chain Reaction (PCR) Tests; Western Blot; Viral Culture Testing
  • 2) By Rapid Test: Lateral Flow Assays (LFA); Immunochromatographic Strip Tests; Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP); Rapid Antigen Tests
  • Companies Mentioned: F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation; Siemens Healthineers AG; Becton Dickinson and Company; Quest Diagnostics Incorporated; Grifols S.A.; Hologic Inc.; PerkinElmer Inc.; bioMerieux SA; Quidel Corporation; Bio-Rad Laboratories Inc.; QIAGEN N.V.; Ortho Clinical Diagnostics; Seegene Inc.; OraSure Technologies Inc.; Meridian Bioscience Inc.; DiaSorin S.p.A.; Trinity Biotech plc
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Viral Diagnostic Test Kits Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Viral Diagnostic Test Kits Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Viral Diagnostic Test Kits Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Viral Diagnostic Test Kits Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Rapid Diagnostic Test Kits
    • 4.2.2 Rising Use Of Molecular-Based Viral Detection
    • 4.2.3 Growing Demand For Point-Of-Care Testing Solutions
    • 4.2.4 Expansion Of Multiplex Viral Assay Development
    • 4.2.5 Enhanced Focus On High-Sensitivity Diagnostic Accuracy

5. Viral Diagnostic Test Kits Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Diagnostic Laboratories
  • 5.3 Clinics
  • 5.4 Research Laboratories
  • 5.5 Public Health Agencies

6. Viral Diagnostic Test Kits Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Viral Diagnostic Test Kits Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Viral Diagnostic Test Kits PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Viral Diagnostic Test Kits Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Viral Diagnostic Test Kits Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Viral Diagnostic Test Kits Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Viral Diagnostic Test Kits Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Viral Diagnostic Test Kits Market Segmentation

  • 9.1. Global Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Traditional Tests, Rapid Test
  • 9.2. Global Viral Diagnostic Test Kits Market, Segmentation By Test Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Direct Fluorescent Antibody (DFA) Test, Immunochromatographic Assay, Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) Based Test, Agglutination Assay, Solid Phase Assay, Flow Through Assay, Other Test Types
  • 9.3. Global Viral Diagnostic Test Kits Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Research Laboratories, Clinics, Hospitals, Other End Users
  • 9.4. Global Viral Diagnostic Test Kits Market, Sub-Segmentation Of Traditional Tests, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Enzyme-Linked Immunosorbent Assay (ELISA), Polymerase Chain Reaction (PCR) Tests, Western Blot, Viral Culture Testing
  • 9.5. Global Viral Diagnostic Test Kits Market, Sub-Segmentation Of Rapid Test, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Lateral Flow Assays (LFA), Immunochromatographic Strip Tests, Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP), Rapid Antigen Tests

10. Viral Diagnostic Test Kits Market Regional And Country Analysis

  • 10.1. Global Viral Diagnostic Test Kits Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Viral Diagnostic Test Kits Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Viral Diagnostic Test Kits Market

  • 11.1. Asia-Pacific Viral Diagnostic Test Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Segmentation By Test Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Viral Diagnostic Test Kits Market

  • 12.1. China Viral Diagnostic Test Kits Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Segmentation By Test Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Viral Diagnostic Test Kits Market

  • 13.1. India Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Segmentation By Test Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Viral Diagnostic Test Kits Market

  • 14.1. Japan Viral Diagnostic Test Kits Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Segmentation By Test Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Viral Diagnostic Test Kits Market

  • 15.1. Australia Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Segmentation By Test Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Viral Diagnostic Test Kits Market

  • 16.1. Indonesia Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Segmentation By Test Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Viral Diagnostic Test Kits Market

  • 17.1. South Korea Viral Diagnostic Test Kits Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Segmentation By Test Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Viral Diagnostic Test Kits Market

  • 18.1. Taiwan Viral Diagnostic Test Kits Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Segmentation By Test Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Viral Diagnostic Test Kits Market

  • 19.1. South East Asia Viral Diagnostic Test Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Segmentation By Test Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Viral Diagnostic Test Kits Market

  • 20.1. Western Europe Viral Diagnostic Test Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Segmentation By Test Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Viral Diagnostic Test Kits Market

  • 21.1. UK Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Segmentation By Test Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Viral Diagnostic Test Kits Market

  • 22.1. Germany Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Segmentation By Test Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Viral Diagnostic Test Kits Market

  • 23.1. France Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Segmentation By Test Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Viral Diagnostic Test Kits Market

  • 24.1. Italy Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Segmentation By Test Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Viral Diagnostic Test Kits Market

  • 25.1. Spain Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Segmentation By Test Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Viral Diagnostic Test Kits Market

  • 26.1. Eastern Europe Viral Diagnostic Test Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Segmentation By Test Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Viral Diagnostic Test Kits Market

  • 27.1. Russia Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Segmentation By Test Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Viral Diagnostic Test Kits Market

  • 28.1. North America Viral Diagnostic Test Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Segmentation By Test Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Viral Diagnostic Test Kits Market

  • 29.1. USA Viral Diagnostic Test Kits Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Segmentation By Test Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Viral Diagnostic Test Kits Market

  • 30.1. Canada Viral Diagnostic Test Kits Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Segmentation By Test Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Viral Diagnostic Test Kits Market

  • 31.1. South America Viral Diagnostic Test Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Segmentation By Test Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Viral Diagnostic Test Kits Market

  • 32.1. Brazil Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Segmentation By Test Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Viral Diagnostic Test Kits Market

  • 33.1. Middle East Viral Diagnostic Test Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Segmentation By Test Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Viral Diagnostic Test Kits Market

  • 34.1. Africa Viral Diagnostic Test Kits Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Viral Diagnostic Test Kits Market, Segmentation By Testing Approach, Segmentation By Test Type, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Viral Diagnostic Test Kits Market Regulatory and Investment Landscape

36. Viral Diagnostic Test Kits Market Competitive Landscape And Company Profiles

  • 36.1. Viral Diagnostic Test Kits Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Viral Diagnostic Test Kits Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Viral Diagnostic Test Kits Market Company Profiles
    • 36.3.1. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

37. Viral Diagnostic Test Kits Market Other Major And Innovative Companies

  • Becton Dickinson and Company, Quest Diagnostics Incorporated, Grifols S.A., Hologic Inc., PerkinElmer Inc., bioMerieux SA, Quidel Corporation, Bio-Rad Laboratories Inc., QIAGEN N.V., Ortho Clinical Diagnostics, Seegene Inc., OraSure Technologies Inc., Meridian Bioscience Inc., DiaSorin S.p.A., Trinity Biotech plc

38. Global Viral Diagnostic Test Kits Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Viral Diagnostic Test Kits Market

40. Viral Diagnostic Test Kits Market High Potential Countries, Segments and Strategies

  • 40.1 Viral Diagnostic Test Kits Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Viral Diagnostic Test Kits Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Viral Diagnostic Test Kits Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer